Publikationer - Kronisk myeloisk leukemi (KML)

Utskriftsvänlig sida

Olsson-Stromberg U, Hoglund M, Bjorkholm M, Braide I, Carlson K, Gahrton G, Grimfors G, Hast R, Lerner R, Linder O, Ljungman P, Lofvenberg E, Malm C, Nilsson PG, Paul C, Rodjer S, Stenke L, Tidefeldt U, Turesson I, Uden AM, Wahlin A, Vilen L, Winqvist I, Zettervall O, Oberg G, Simonsson B. Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase. Leuk Lymphoma 2006 Sep; 47(9): 1768-73.

Simonsson B, Oberg G, Bjoreman M, Bjorkholm M, Carneskog J, Karlsson K, Gahrton G, Grimfors G, Hast R, Karle H, Linder O, Ljungman P, Nielsen JL, Nilsson J, Lofvenberg E, Malm C, Olsson K, Olsson-Stromberg U, Paul C, Stenke L, Stentoft J, Turesson I, Uden AM, Wahlin A, Vilen L, Weis-Bjerrum O. Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up. Acta Haematol 2005; 113(3): 155-62.

Olsson-Stromberg U, Simonsson B, Ahlgren T, Bjorkholm M, Carlsson K, Gahrton G, Hast R, Lofvenberg E, Linder O, Ljungman P, Malm C, Paul C, Rodjer S, Turesson I, Uden AM, Wahlin A, Killander A, Wadman B, Westin J, Vikrot O, Zettervall O, Oberg G. Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival. Hematol J 2004; 5(6): 62-6.

Axdorph U, Stenke L, Grimfors G, Carneskog J, Hansen J, Linder O, Ljungman P, Lofvenberg E, Malm C, Simonsson B, Turesson I, Vilen L, Uden AM, Bjorkholm M. Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML Group. Br J Haematol 2002 Sep; 118(4): 1048-54.